<DOC>
	<DOCNO>NCT01357798</DOCNO>
	<brief_summary>The objective study evaluate Botulinum Toxin Type A superior 0,9 % saline treatment cranial Allodynia patient headache . Hypothesis H ( 0 ) : Botulinum Toxin Type A superior 0,9 % saline treatment cranial Allodynia patient headache H ( 1 ) : Botulinum Toxin Type A superior 0,9 % saline treatment cranial Allodynia patient headache</brief_summary>
	<brief_title>Botulinum Toxin Type A Treatment Cranial Allodynia Patients With Headache</brief_title>
	<detailed_description>After adequation approve ethic committee research involve human selection patient tension headache migraine accord The International Classification Headache Disorders , 2nd Edition ( ICHD II ) start Headache Clinic Alcides Carneiro Universitary Hospital . Those select orient regard study step potential risk procedure . The patient catalog occurrence headache use analgesic 30 day daily headache . At end month patient evaluate physician experienced treatment headache define occurrence pain allodynia scalp . Data gather consultation record standardized questionnaire study . The questionnaire divide : Patient 's identification , illustration pain area allodynea point , pain intensity Visual Analogue Scale ( VAS ) finally medication use collect Headache Diary . The people randomize block permutation , security equal distribution two group ( number previous determine ) . One group 0,9 % saline Botulinum Toxin A. Finishing application Researcher ( Who n't know result randomization infiltrate contain ) . The patient submit three evaluation : first , 30 day infiltration , doctor n't participate anterior step analyze pain intensity Visual Analogue Scale ( VAS ) , episode headache use painkiller trough Headache Diary . The Doctor ask patient localize , exist , allodynia point . The others evolution visit happen 60 90 day application , doctor use method . Another professional , n't know anterior step study , static data analyze .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Hyperalgesia</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Patients diagnose tensional headache migraine The International Classification Headache Disorders , 2nd Edition ICHD II Patients sex old 18 year Fill diagnostics criterion one type primary headache ICHD II Another neurological disease systemic illness cause headache . Condition contraindicate use Study 's Medication . Cognitive impairment Use botulinum toxin within last six month Blood , liver , kidney disorder pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Headache</keyword>
	<keyword>Allodynia</keyword>
	<keyword>Botulinum Toxin Type A</keyword>
</DOC>